Sign up to save your podcasts
Or
Share The Lancet Respiratory Medicine: December 23, 2013
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Respiratory Medicine: December 23, 2013
Geoff Bellingan discusses the effect of intravenous-beta-1a on lung CD73 expression and on ARDS mortality.
View all episodes
By The Lancet Respiratory MedicineGeoff Bellingan discusses the effect of intravenous-beta-1a on lung CD73 expression and on ARDS mortality.